Extracellular vesicles as potential biomarkers of acute graft-vs-host disease

The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review

(2016) Alaa M. Ali et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation

(2016) Silvia Gimondi et al.   EXPERIMENTAL HEMATOLOGY

Charge-based precipitation of extracellular vesicles

(2016) Maria Chiara Deregibus et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Identification and validation of biomarkers associated with acute and chronic graft versus host disease

(2015) S S Ahmed et al.   BONE MARROW TRANSPLANTATION

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

(2015) T Matsumura et al.   BRITISH JOURNAL OF CANCER

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma

(2015) Karen Chiam et al.   JOURNAL OF GASTROINTESTINAL SURGERY

CD31 signals confer immune privilege to the vascular endothelium

(2015) Kenneth Cheung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML

(2015) Noah I. Hornick et al.   Scientific Reports

CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells

(2014) M. Clement et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Changes in Circulating Endothelial Cells Count Could Become a Valuable Tool in the Diagnostic Definition of Acute Graft-Versus-Host Disease

(2014) Camillo Almici et al.   TRANSPLANTATION

Targeting Th17 cells in autoimmune diseases

(2014) Jianfei Yang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor Registry

(2013) Roberto Passera et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Inflammatory neovascularization during graft-versus-host disease is regulated by  v integrin and miR-100

(2013) F. Leonhardt et al.   BLOOD

Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease

(2013) B. Xiao et al.   BLOOD

Biologic markers of chronic GVHD

(2013) J Pidala et al.   BONE MARROW TRANSPLANTATION

Graft-versus-host disease biomarkers: omics and personalized medicine

(2013) Sophie Paczesny et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

An immunologist's guide to CD31 function in T-cells

(2013) F. M. Marelli-Berg et al.   JOURNAL OF CELL SCIENCE

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

(2013) Rainer Storb et al.   JOURNAL OF CLINICAL ONCOLOGY

Repression of PDGF-R-α after cellular injury involves TNF-α, formation of a c-Fos-YY1 complex, and negative regulation by HDAC

(2012) Ning Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease

(2012) John E. Levine et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Discovery and validation of graft-versus-host disease biomarkers

(2012) S. Paczesny   BLOOD

Regulation of acute graft-versus-host disease by microRNA-155

(2012) P. Ranganathan et al.   BLOOD

Advances in predicting acute GVHD

(2012) Andrew C. Harris et al.   BRITISH JOURNAL OF HAEMATOLOGY

Microvesicles Derived from Endothelial Progenitor Cells Enhance Neoangiogenesis of Human Pancreatic Islets

(2012) Vincenzo Cantaluppi et al.   CELL TRANSPLANTATION

Autoimmunity in 2011

(2012) Carlo Selmi   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Role of Cytokines in the Pathophysiology of Acute Graft-Versus-Host Disease (GVHD)– Are Serum/Plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)?

(2012) Tomomi Toubai et al.   Current Stem Cell Research & Therapy

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma

(2011) L. Giaccone et al.   BLOOD

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

(2011) J. Pidala et al.   HAEMATOLOGICA

Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma

(2011) George Tsirakis et al.   HEMATOLOGICAL ONCOLOGY

Implications of TNF-α in the pathogenesis and management of GVHD

(2011) John E. Levine   INTERNATIONAL JOURNAL OF HEMATOLOGY

Clearance of platelet microparticles in vivo

(2011) A. Rank et al.   PLATELETS

Biomarkers of immune activation to screen for severe, acute GVHD

(2010) K J August et al.   BONE MARROW TRANSPLANTATION

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation

(2010) John A Hansen et al.   CURRENT OPINION IN HEMATOLOGY

Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance

(2010) L. Ma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

(2008) B. Bruno et al.   BLOOD

CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease

(2008) T. Hori et al.   BLOOD

Fibroblast Dysfunction Is a Key Factor in the Non-Healing of Chronic Venous Leg Ulcers

(2008) Ivan B. Wall et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY